Mode
Text Size
Log in / Sign up
N/A N=200 Randomized Diagnostic

Fasting Versus Fed: Effect of Oral Intake Prior to the Glucose Tolerance Test in Pregnancy

Gestational Diabetes · Diagnoses Disease · Pregnancy in Diabetic · Glucose, High Blood

Enrolled (actual)
200
Serious AEs
1.0%
Results posted
Nov 2022
Primary outcome: Primary: Number of Participants With a Positive Gestational Diabetes Mellitus (GDM) Screen (>= 140 mg/dL) on the 1 Hour 50-g Oral Glucose Tolerance Test (OGTT) — 31; 13 Participants — p=0.002

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Fasting before gestational diabetes screen (Behavioral); Per oral intake of food and drink (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
Female
Sponsor
Stanford University
Primary completion
Jun 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants With a Positive Gestational Diabetes Mellitus (GDM) Screen (>= 140 mg/dL) on the 1 Hour 50-g Oral Glucose Tolerance Test (OGTT)
31; 13 0.002 sig
SECONDARY
Mean Gestational Age at OGTT Screen
25.7; 25.8
SECONDARY
Mean Glucose Level at the OGTT Screen
127.7; 113.3
SECONDARY
Number of Participants With Positive GDM Diagnosis Based on the OGTT
8; 2
SECONDARY
Average Time of Last Oral Intake Prior to the OGTT Screen
10.7; 1.4
SECONDARY
Number of Participants With Positive GDM Diagnosis
12; 5
SECONDARY
Mean Gestational Age at Delivery
272; 272
SECONDARY
Number of Participants Who Delivered Vaginally
67; 53
SECONDARY
Number of Participants Who Delivered Via Operative Vaginal Birth
3; 7
SECONDARY
Number of Participants Who Delivered Vaginally After a Prior Cesarean Section
2; 1
SECONDARY
Number of Participants Who Delivered Via a Primary Cesarean Section
17; 21
SECONDARY
Number of Participants Who Delivered Via a Repeat Cesarean Section
7; 14
SECONDARY
Number of Participants Complicated by Shoulder Dystocia at Delivery
0; 1
SECONDARY
Number of Participants Complicated by Third or Fourth Degree Perineal Laceration
2; 4
SECONDARY
Number of Participants With Post-partum Hemorrhage
16; 10
SECONDARY
Number of Participants Diagnosed With a Hypertensive Disorder of Pregnancy
22; 15
SECONDARY
Length of Postnatal Stay From Delivery to Discharge
2.3; 2.4
SECONDARY
Number of Participants Who Had a Postpartum Readmission
4; 6
SECONDARY
Number of Participants With Type 2 Diabetes Mellitus Diagnosis Post-partum
1; 0
SECONDARY
Mean Neonatal Birthweight
3231; 3268
SECONDARY
Number of Neonates With Birth Weight More Than 4000 Grams
6; 6
SECONDARY
Number of Neonates Considered Large for Gestational Age (LGA)
6; 7
SECONDARY
Number of Neonates Considered Small for Gestational Age (SGA)
6; 9
SECONDARY
Number of Neonates Admitted to the Neonatal Intensive Care Unit (NICU)
4; 7
SECONDARY
Number of Neonates With Hyperbilirubinemia
7; 9
SECONDARY
Number of Neonates With Hypoglycemia
9; 5
SECONDARY
Number of Neonates Diagnosed With Respiratory Distress Syndrome
7; 7
SECONDARY
Number of Neonates Exclusively Breastfeeding at Time of Hospital Discharge
62; 59

Summary

Studies suggest that the timing interval between oral intake and the 1-hour gestational diabetes screen may have a significant impact on gestational diabetes screening glucose levels. The investigators plan to conduct a prospective randomized trial comparing a 6-hour fast versus liberal oral intake within 2 hours prior to the glucose tolerance test in pregnancy in order to evaluate the effect of the fasting versus the fed state on routine gestational diabetes screening results.

Eligibility Criteria

Inclusion Criteria

  • Pregnant patients 18 years and older
  • Singleton gestation
  • Pregnancy managed at Lucile Packard Children's Hospital (LPCH) Stanford outpatient obstetrics clinic
  • Planned delivery at Lucile Packard Children's Hospital (LPCH) Stanford Labor and Delivery unit

Exclusion Criteria

  • Pregestational diabetes
  • Gestational diabetes diagnosed in the 1st trimester
  • Less than 18 years of age
  • Planned delivery outside LPCH
  • Diabetes medication use prior to pregnancy
  • Inability to give informed consent
  • Chronic steroid use in pregnancy
  • Less than 24 weeks of gestation at the time of the 1 hour oral glucose tolerance test
  • Prior history of bariatric surgery
  • Multifetal gestation
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04547023). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search